T. Rowe Price Associates
LXRX icon

T. Rowe Price Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-92,248
Closed -$43K 3108
2025
Q1
$43K Buy
92,248
+14,746
+19% +$6.87K ﹤0.01% 2943
2024
Q4
$57K Sell
77,502
-39,677
-34% -$29.2K ﹤0.01% 2909
2024
Q3
$184K Hold
117,179
﹤0.01% 2679
2024
Q2
$197K Buy
117,179
+11,864
+11% +$19.9K ﹤0.01% 2595
2024
Q1
$253K Buy
105,315
+4,624
+5% +$11.1K ﹤0.01% 2512
2023
Q4
$155K Hold
100,691
﹤0.01% 2614
2023
Q3
$110K Sell
100,691
-7,695
-7% -$8.41K ﹤0.01% 2641
2023
Q2
$249K Sell
108,386
-48,235
-31% -$111K ﹤0.01% 2443
2023
Q1
$381K Sell
156,621
-37,492
-19% -$91.2K ﹤0.01% 2229
2022
Q4
$371K Buy
194,113
+838
+0.4% +$1.6K ﹤0.01% 2282
2022
Q3
$464K Sell
193,275
-4,166
-2% -$10K ﹤0.01% 2157
2022
Q2
$367K Buy
197,441
+43,509
+28% +$80.9K ﹤0.01% 2348
2022
Q1
$322K Buy
153,932
+10,300
+7% +$21.5K ﹤0.01% 2516
2021
Q4
$566K Buy
143,632
+14,064
+11% +$55.4K ﹤0.01% 2327
2021
Q3
$623K Hold
129,568
﹤0.01% 2265
2021
Q2
$595K Buy
129,568
+26,637
+26% +$122K ﹤0.01% 2299
2021
Q1
$604K Sell
102,931
-77,144
-43% -$453K ﹤0.01% 2279
2020
Q4
$616K Sell
180,075
-157,300
-47% -$538K ﹤0.01% 2158
2020
Q3
$486K Hold
337,375
﹤0.01% 2100
2020
Q2
$673K Buy
337,375
+108,900
+48% +$217K ﹤0.01% 1942
2020
Q1
$446K Buy
228,475
+35,100
+18% +$68.5K ﹤0.01% 2038
2019
Q4
$803K Buy
193,375
+131,545
+213% +$546K ﹤0.01% 1975
2019
Q3
$186K Buy
61,830
+188
+0.3% +$566 ﹤0.01% 2386
2019
Q2
$388K Buy
61,642
+26,900
+77% +$169K ﹤0.01% 2209
2019
Q1
$193K Buy
34,742
+800
+2% +$4.44K ﹤0.01% 2403
2018
Q4
$225K Buy
33,942
+476
+1% +$3.16K ﹤0.01% 2368
2018
Q3
$357K Sell
33,466
-141
-0.4% -$1.5K ﹤0.01% 2271
2018
Q2
$403K Buy
33,607
+147
+0.4% +$1.76K ﹤0.01% 2230
2018
Q1
$287K Buy
33,460
+284
+0.9% +$2.44K ﹤0.01% 2298
2017
Q4
$328K Sell
33,176
-20,560
-38% -$203K ﹤0.01% 2233
2017
Q3
$660K Buy
53,736
+20,600
+62% +$253K ﹤0.01% 1960
2017
Q2
$545K Hold
33,136
﹤0.01% 2031
2017
Q1
$475K Buy
33,136
+17
+0.1% +$244 ﹤0.01% 2083
2016
Q4
$458K Hold
33,119
﹤0.01% 2082
2016
Q3
$598K Sell
33,119
-17,600
-35% -$318K ﹤0.01% 1938
2016
Q2
$728K Buy
50,719
+1,620
+3% +$23.3K ﹤0.01% 1814
2016
Q1
$587K Buy
49,099
+25,100
+105% +$300K ﹤0.01% 1901
2015
Q4
$319K Sell
23,999
-5,700
-19% -$75.8K ﹤0.01% 2131
2015
Q3
$319K Buy
29,699
+5,900
+25% +$63.4K ﹤0.01% 2121
2015
Q2
$192K Sell
23,799
-62,001
-72% -$500K ﹤0.01% 2357
2015
Q1
$81K Sell
85,800
-5,987,790
-99% -$5.65M ﹤0.01% 2485
2014
Q4
$5.53M Sell
6,073,590
-73,000
-1% -$66.4K ﹤0.01% 1444
2014
Q3
$8.67M Buy
6,146,590
+22,500
+0.4% +$31.7K ﹤0.01% 1340
2014
Q2
$9.86M Sell
6,124,090
-330,600
-5% -$532K ﹤0.01% 1322
2014
Q1
$11.2M Sell
6,454,690
-27,600
-0.4% -$47.8K ﹤0.01% 1272
2013
Q4
$11.7M Sell
6,482,290
-7,349,756
-53% -$13.2M ﹤0.01% 1247
2013
Q3
$32.8M Sell
13,832,046
-588,280
-4% -$1.39M 0.01% 953
2013
Q2
$31.3M Buy
+14,420,326
New +$31.3M 0.01% 939